Stocks and InvestingStocks and Investing
Thu, April 1, 2021
Wed, March 31, 2021
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021

Elliot Wilbur Maintained (ADMA) at Buy with Decreased Target to $6 on, Mar 26th, 2021


Published on 2024-10-27 16:03:16 - WOPRAI, Elliot Wilbur
  Print publication without navigation


Elliot Wilbur of Raymond James, Maintained "ADMA Biologics, Inc." (ADMA) at Buy with Decreased Target from $7 to $6 on, Mar 26th, 2021.

Elliot has made no other calls on ADMA in the last 4 months.



There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Elliot's Rating of Hold.



This is the rating of the analyst that currently disagrees with Elliot


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Monday, January 4th, 2021